Stephen Davis's Net Worth
$25.3 Million
Who is Stephen Davis?
Stephen Davis has an estimated net worth of $25.3 Million. This is based on reported shares across multiple companies, which include HERON THERAPEUTICS, INC. /DE/, ACADIA PHARMACEUTICALS INC, BELLICUM PHARMACEUTICALS, INC, Furiex Pharmaceuticals, Inc., TRIMERIS INC, Ardea Biosciences, Inc./DE, and NEUROGEN CORP.
SEC CIK
Stephen Davis's CIK is 0001131146
Past Insider Trading and Trends
2021 was Stephen Davis's most active year for acquiring shares with 13 total transactions. Stephen Davis's most active month to acquire stocks was the month of November. 2011 was Stephen Davis's most active year for disposing of shares, totalling 17 transactions. Stephen Davis's most active month to dispose stocks was the month of May. 2019 saw Stephen Davis paying a total of $5,895,000.00 for 653,985 shares, this is the most they've acquired in one year. In 2019 Stephen Davis cashed out on 608,920 shares for a total of $13,992,324.98, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HERON THERAPEUTICS, INC. /DE/ (HRTX) Snapshot price: $1.81
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +286.80% | 38.58K |
—
|
—
| 52.03K |
Dec 16
| |||
Form 4
| +348.40% | 10.45K |
—
|
—
| 13.45K |
Dec 22
| |||
Form 4
|
∞
| 3K |
—
|
—
| 3K |
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
| +737.55% | 17.68K |
$7.82 | $22.64 | 20.08K |
Sep 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -24.48% | -31.09K |
—
|
—
| 95.89K |
Feb 16
| |||
Form 4
| +308.45% | 95.89K |
—
|
—
| 126.98K |
May 20
| |||
Form 4
|
∞
| 31.09K |
—
|
—
| 31.09K |
Feb 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACADIA PHARMACEUTICALS INC (ACAD) Snapshot price: $16.07
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +19.44% | 30.37K |
$15.28 | -$485,094.16 | 186.56K |
Aug 16 - Aug 19
| |||
Form 4
| +7.60% | 10.96K |
$16.94 | -$193,573.38 | 155.23K |
May 1 - May 2
| |||
Form 4
| +21.39% | 25.43K |
$17.87 | -$474,877.38 | 144.27K |
Apr 5 - Apr 8
| |||
Form 4
| +16.64% | 16.95K |
$17.90 | -$317,080.60 | 118.84K |
Mar 25 - Mar 27
| |||
Form 4
| +5.56% | 5.37K |
$24.67 | -$137,584.59 | 101.89K |
Feb 23 - Feb 26
| |||
Form 4
| +6.39% | 5.8K |
$29.96 | -$111,810.72 | 96.52K |
Jan 6 - Jan 8
| |||
Form 4
| +142.90% | 52.44K |
$21.96 | -$1,132,323.48 | 89.13K |
Oct 5 - Oct 6
| |||
Form 4
|
—
|
0
|
$25.41 | -$927,350.00 | 36.7K |
Jul 14
| |||
Form 4
| -66.12% | -71.60K |
$25.04 | -$1,792,898.88 | 36.7K |
Jul 11 - Jul 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +7.78% | 7.82K |
$21.18 | -$165,331.08 | 108.3K |
Apr 29 - May 1
| |||
Form 4
| +9.54% | 8.75K |
$18.16 | -$155,849.12 | 100.48K |
Apr 5 - Apr 6
| |||
Form 4
| +8.38% | 7.09K |
$18.78 | -$72,321.78 | 91.73K |
Feb 23 - Feb 24
| |||
Form 4
| +7.12% | 5.62K |
$17.13 | -$66,876.69 | 84.63K |
Jan 6 - Jan 9
| |||
Form 4
| +4.13% | 3.13K |
$15.81 | -$44,331.24 | 79.01K |
Oct 15
| |||
Form 4
| +15.43% | 10.14K |
$18.18 | -$99,691.36 | 75.88K |
Apr 29 - May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 4
| +11.95% | 7.02K |
$23.80 | -$93,486.40 | 65.73K |
Feb 23
| |||
Form 4
| +10.98% | 5.81K |
$23.05 | -$85,699.90 | 58.72K |
Jan 6
| |||
Form 4
| +5.96% | 2.98K |
$17.41 | -$51,585.83 | 52.91K |
Oct 15 - Oct 18
| |||
Form 4
| +18.72% | 7.78K |
$20.33 | -$159,590.50 | 49.31K |
Apr 29 - Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
| +31.06% | 17.05K |
$50.61 | -$718,408.95 | 71.96K |
Feb 4
| |||
Form 4
| +32.77% | 6.04K |
$53.34 | -$185,836.56 | 24.48K |
Jan 6
| |||
Form 4
| +25.21% | 2.98K |
$42.56 | -$125,977.60 | 14.79K |
Oct 15 - Oct 16
| |||
Form 4
|
—
|
0
|
$32.84 | -$5,274,691.76 | 11.81K |
Scheduled
|
May 13 - May 14
| ||
Form 4
| +299.76% | 8.86K |
$49.21 | -$333,151.70 | 11.81K |
Apr 29 - Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
$36.00 | -$4,903,799.93 | 2.95K |
Scheduled
|
Dec 5
| ||
Form 4
|
∞
| 2.95K |
$39.65 | -$118,275.95 | 2.95K |
Oct 15
| |||
Form 4
|
—
|
0
|
$29.90 | -$3,075,249.10 |
0
|
Scheduled
|
Oct 9 - Oct 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BELLICUM PHARMACEUTICALS, INC (BLCM) Snapshot price: $0.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +120.32% | 74.74K |
—
|
—
| 136.85K |
Jan 3
| |||
Form 4
| +231.90% | 43.4K |
—
|
—
| 62.12K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
∞
| 18.71K |
—
|
—
| 18.71K |
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Furiex Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -9.31K |
—
|
—
|
0
|
Jul 2
| |||
Form 4
| +62.50% | 3.58K |
—
|
—
| 9.31K |
Feb 28
| |||
Form 4
|
∞
| 5.73K |
—
|
—
| 5.73K |
May 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TRIMERIS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
| No matching records found | |||||||||